A Randomized, Double-blind, Multiple-dose, Placebo-controlled Study to Evaluate the Efficacy and Safety of Etodolac-lidocaine Patch Applied Once Daily in Subjects Experiencing Acute Delayed Onset Muscle Soreness
Phase of Trial: Phase III
Latest Information Update: 21 Sep 2016
At a glance
- Drugs Etodolac/lidocaine (Primary)
- Indications Acute pain
- Focus Therapeutic Use
- Sponsors MEDRx
- 08 Sep 2016 Status changed from recruiting to completed.
- 22 Mar 2016 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 04 Mar 2016 New trial record